AlzChem Group AG
ALZCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $161 | $143 | $145 | $139 |
| % Growth | 12.7% | -1.2% | 4.1% | – |
| Cost of Goods Sold | $109 | $42 | $53 | $44 |
| Gross Profit | $52 | $101 | $92 | $95 |
| % Margin | 32.2% | 70.9% | 63.5% | 68.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $4 | $0 | $0 |
| SG&A Expenses | $29 | $8 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $4 | $0 | $0 |
| Other Operating Expenses | -$4 | $69 | $71 | $75 |
| Operating Expenses | $25 | $77 | $71 | $75 |
| Operating Income | $27 | $24 | $21 | $21 |
| % Margin | 16.8% | 17% | 14.4% | 14.9% |
| Other Income/Exp. Net | -$1 | -$2 | -$1 | $0 |
| Pre-Tax Income | $27 | $22 | $20 | $21 |
| Tax Expense | $7 | $6 | $6 | $6 |
| Net Income | $19 | $16 | $15 | $15 |
| % Margin | 11.9% | 11.1% | 10.1% | 10.9% |
| EPS | 1.89 | 1.57 | 1.44 | 1.49 |
| % Growth | 20.4% | 9% | -3.4% | – |
| EPS Diluted | 1.89 | 1.57 | 1.44 | 1.49 |
| Weighted Avg Shares Out | 10 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 10 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $8 | $6 | $7 | $7 |
| EBITDA | $36 | $30 | $28 | $29 |
| % Margin | 22.3% | 20.8% | 19.4% | 21% |